BACKGROUND: About 10% of pancreatic cancer patients are aged ≤50 at diagnosis and defined as Early Onset Pancreatic Cancer (EOPC). There is limited information regarding risk factors for EOPC occurrence and their outcome. AIM: To investigate risk factors, presentation features and outcome of EOPC patients. METHODS: Consecutive, histologically confirmed, pancreatic cancer patients enrolled. Data regarding environmental and genetic risk factors, clinical and pathological information, treatment and survival were recorded. EOPC patients (aged ≤50 at diagnosis) were compared to older subjects. RESULTS: Twenty-five of 293 patients (8.5%) had EOPC. There was no difference regarding sex distribution, medical conditions and alcohol intake between EOPC and older subjects. EOPC patients were more frequently current smokers (56% vs 28% p = 0.001) and started smoking at a significantly lower mean age (19.8 years, 95%CI 16.7-22.9) as compared to older patients (26.1, 95%CI 24.2-28) (p = 0.001). Current smoking (OR 7.5; 95%CI 1.8-30; p = 0.004) and age at smoking initiation (OR 0.8 for every increasing year; 95%CI 0.7-0.9; p = 0.01) were significant and independent risk factors for diagnosis of EOPC. There were no differences regarding genetic syndromes and pancreatic cancer family history. EOCP presented less frequently with jaundice (16% vs 44%, p = 0.006) and had a higher rate of unresectable disease, albeit not significantly (84% vs 68%, p = 0.1). EOPC patients were more frequently fit for surgery or chemotherapy than their counterpart, resulting in similar stage-specific survival probability. CONCLUSION: EOPC seems related to active and early smoking but not to familial syndromes. Young patients display aggressive disease but not worse outcome.
BACKGROUND: About 10% of pancreatic cancerpatients are aged ≤50 at diagnosis and defined as Early Onset Pancreatic Cancer (EOPC). There is limited information regarding risk factors for EOPC occurrence and their outcome. AIM: To investigate risk factors, presentation features and outcome of EOPC patients. METHODS: Consecutive, histologically confirmed, pancreatic cancerpatients enrolled. Data regarding environmental and genetic risk factors, clinical and pathological information, treatment and survival were recorded. EOPC patients (aged ≤50 at diagnosis) were compared to older subjects. RESULTS: Twenty-five of 293 patients (8.5%) had EOPC. There was no difference regarding sex distribution, medical conditions and alcohol intake between EOPC and older subjects. EOPC patients were more frequently current smokers (56% vs 28% p = 0.001) and started smoking at a significantly lower mean age (19.8 years, 95%CI 16.7-22.9) as compared to older patients (26.1, 95%CI 24.2-28) (p = 0.001). Current smoking (OR 7.5; 95%CI 1.8-30; p = 0.004) and age at smoking initiation (OR 0.8 for every increasing year; 95%CI 0.7-0.9; p = 0.01) were significant and independent risk factors for diagnosis of EOPC. There were no differences regarding genetic syndromes and pancreatic cancer family history. EOCP presented less frequently with jaundice (16% vs 44%, p = 0.006) and had a higher rate of unresectable disease, albeit not significantly (84% vs 68%, p = 0.1). EOPC patients were more frequently fit for surgery or chemotherapy than their counterpart, resulting in similar stage-specific survival probability. CONCLUSION: EOPC seems related to active and early smoking but not to familial syndromes. Young patients display aggressive disease but not worse outcome.
Authors: Irit Ben-Aharon; Moshe Elkabets; Raphael Pelossof; Kenneth H Yu; Christine A Iacubuzio-Donahue; Steven D Leach; Maeve A Lowery; Karyn A Goodman; Eileen M O'Reilly Journal: Clin Cancer Res Date: 2019-01-07 Impact factor: 12.531
Authors: Ali Abbaszadeh Kasbi; Mohammed Ali Ashary; Mizba Baksh; Samuel Nussbaum; Kristopher Attwood; Emmanuel Gabriel Journal: Cancer Diagn Progn Date: 2022-01-03
Authors: Mark B Ulanja; Alastair E Moody; Bryce D Beutler; Daniel Antwi-Amoabeng; Ganiyu A Rahman; Olatunji B Alese Journal: Oncotarget Date: 2022-06-15
Authors: Erica J Childs; Kari G Chaffee; Steven Gallinger; Sapna Syngal; Ann G Schwartz; Michele L Cote; Melissa L Bondy; Ralph H Hruban; Stephen J Chanock; Robert N Hoover; Charles S Fuchs; David N Rider; Laufey T Amundadottir; Rachael Stolzenberg-Solomon; Brian M Wolpin; Harvey A Risch; Michael G Goggins; Gloria M Petersen; Alison P Klein Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-05-16 Impact factor: 4.254
Authors: Jessica L Petrick; Nelsy Castro-Webb; Hanna Gerlovin; Traci N Bethea; Shanshan Li; Edward A Ruiz-Narváez; Lynn Rosenberg; Julie R Palmer Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-07-01 Impact factor: 4.254
Authors: Lily V Saadat; Joanne F Chou; Mithat Gonen; Kevin C Soares; T Peter Kingham; Anna M Varghese; William R Jarnagin; Michael I D'Angelica; Jeffrey A Drebin; Eileen M O'Reilly; Alice C Wei Journal: Cancer Date: 2021-07-06 Impact factor: 6.921